SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2230Myriad Genetics Sets Record and Distribution Dates for Spin-Off of Myriad PharmaA.J. Mullen-6/4/2009
2229citi: Myriad Genetics Inc (MYGN) Gene Patent Lawsuit Not a Threat to MYGN Franchmopgcw-5/23/2009
2228NYT: Cancer Patients Challenge the Patenting of a Gene By JOHN SCHWARTZ Publishmopgcw-5/13/2009
2227Seeking Alpha:Myriad Genetics F3Q09 Earnings Call Transcript May 5, 2009 10:00 mopgcw15/7/2009
2226Rethinking Myriad After 'Those in the Know' Have Left by: Trader Mark [sim1-5/5/2009
2225Myriad Genetics Launches OnDose, Its Seventh Molecular Diagnostic Product OnDossim1-4/27/2009
2224Yeah, and we always believe in Hobden's words, correct?????????? :-( Infinscaram(o)uche-4/15/2009
2223Myriad Pharmaceuticals Receives IND Approval for New Cancer Drug Novel Hsp90 Inhsim1-4/8/2009
2222The phantom menace of gene patents Commentary Nature 458, 407-408 (26 March 20sim1-3/26/2009
2221The dangers of diagnostic monopolies Commentary Nature 458, 405-406 (26 March sim1-3/25/2009
2220Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer sim1-3/25/2009
2219Leerink Swann initiates MYGN with an Outperform. Market Report -- Short Storiesim1-3/24/2009
2218Myriad Genetics Announces 2-for-1 Stock Split * Tuesday February 24, 2009, sim1-2/24/2009
2217cc transcript: seekingalpha.commopgcw12/4/2009
2216Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009 6:30 AM mopgcw-2/3/2009
2215SeekingAlpha: Myriad Genetics - A Diagnostics Heavy Hitter by: Trader Mark Januamopgcw-1/21/2009
2214Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat Bevirimat, a First-in-sim1-1/21/2009
2213<Well it was a good trade up until about 3:30 yesterday...much better than mykenhott-1/15/2009
2212Just checked, Myriad has no patent protection for both BRCAs in Israel. So a locidos-1/15/2009
2211Well it was a good trade up until about 3:30 yesterday...much better than my expmopgcw-1/9/2009
2210<i sold some feb 80 calls here> That is like a red cape to a blinded bullkenhott-1/9/2009
2209fwiw, i sold some feb 80 calls here.. someone is buying them big...mopgcw-1/5/2009
2208Piper Jaffray Calls Myriad Genetics (MYGN) A Top 2009 Pick 9:40 AM EST January 5mopgcw-1/5/2009
2207Feuerstein’s <i>Best Biotech CEO</i> award is a freaking joke (IMO):DewDiligence_on_SI-12/16/2008
2206New test aims to predict breast cancer risk better By MARILYNN MARCHIONE [Desim1-12/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News